All subcategories » published RCT
Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial.
primary studies published RCT
Details- 2017
- Kanhere M
Improvement in exercise duration, lung function and well-being in G551D-Cystic Fibrosis patients: a double-blind, placebo-controlled, randomised, cross-over study with ivacaftor.
primary studies published RCT
Details- 2017
- Keating DT
Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
primary studies published RCT
Details- 2017
- Lechtzin N
In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.
primary studies published RCT
Details- 2017
- McGarry ME
Physical Activity Counseling for Children With Cystic Fibrosis.
primary studies published RCT
Details- 2017
- Moola FJ
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.
primary studies published RCT
Details- 2017
- Muhlebach MS
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
primary studies published RCT
Details- 2017
- Nenna R
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.
primary studies published RCT
Details- 2017
- Ratjen F
Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis.
primary studies published RCT
Details- 2017
- Rowe SM
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
primary studies published RCT
Details- 2017
- Rowe SM